跳至主要内容
临床试验/IRCT20210202050229N1
IRCT20210202050229N1已完成3 期

The effect of Cassia fistula syrup on quality of life in patients undergoing hemodialysis with constipation

Shahed University0 个研究点目标入组 70 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
70

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • Age 18 years and above
  • Dialysis adequacy index above 1/2
  • At least 3 months have passed since the start of hemodialysis
  • Having at least two of the criteria of Rome-3

排除标准

  • Sensitivity to plant compounds, especially Cassia fistula
  • History of active infection in the last month
  • Absence of gastrointestinal diseases including irritable bowel syndrome, secondary constipation or neurological diseases (Parkinson's, depression, etc.) Non-neurological diseases (hypothyroidism, hypokalemia, etc.)
  • History of any gastrointestinal surgery

研究者

相似试验

The effect of Cassia fistula syrup on constipatio | 临床试验